Skip to main content
. 2019 Jan 15;39(1):BSR20181335. doi: 10.1042/BSR20181335

Figure 1. The relative expression of serum level of MALAT1 (fold change) in MS, RRMS and SPMS patients in comparison with normal healthy controls.

Figure 1

Data are represented by box plot (median, upper and lower quartiles). The horizontal dotted line represents the expression level of normal group. The results showed that the fold change of serum expression level of MALAT1 in MS patients was significantly higher than that in normal subjects, P=0.004. The expression of MALAT1 in MS subgroups showed significant elevation of the relative expression of fold change of serum MALAT1 in SPMS patients compared with normal subjects (P<0.0001), and no significant difference between RRMS patients relative to normal subjects (P=0.119).